Fair Value of Financial Instruments - Schedule of Changes in the Fair Value Level 3 Warrants (Details) - Level 3 [Member] - USD ($) $ in Thousands |
6 Months Ended | |||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
|||
| Schedule of Changes in the Fair Value Level 3 Warrants [Line Items] | ||||
| Beginning balance | $ 2,287 | |||
| Issuance of Private Placement Warrants | 28,745 | |||
| Issuance of Common Warrants | 4,531 | |||
| Repricing of warrants under the Inducement Letter Agreements | [1] | 3,300 | ||
| Common Warrants exercise | (1) | |||
| Change in fair value | (5,712) | (26,458) | ||
| Ending balance | $ 4,405 | $ 2,287 | ||
| ||||
| X | ||||||||||
- Definition The amount of repricing of warrants under the inducement letter agreements. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|